P

Inventor

SWANSON RYAN

US25 patents
⚠️ This page may combine multiple inventors who share the name “SWANSON RYAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ALPINE IMMUNE SCIENCES INC

23 patents
US11117949B2Sep 14, 2021

CD80 variant immunomodulatory proteins and uses thereof

ALPINE IMMUNE SCIENCES INC13 citations94
US11117948B2Sep 14, 2021

CD80 variant immunomodulatory proteins and uses thereof

ALPINE IMMUNE SCIENCES INC13 citations94
US11117950B2Sep 14, 2021

CD80 variant immunomodulatory proteins and uses thereof

ALPINE IMMUNE SCIENCES INC13 citations94
US11096988B2Aug 24, 2021

CD80 variant immunomodulatory proteins and uses thereof

ALPINE IMMUNE SCIENCES INC13 citations94
US11078282B2Aug 3, 2021

CD80 variant immunomodulatory proteins and uses thereof

ALPINE IMMUNE SCIENCES INC17 citations93
US11639375B2May 2, 2023

CD80 variant immunomodulatory proteins and uses thereof

ALPINE IMMUNE SCIENCES INC4 citations85
US11319359B2May 3, 2022

Immunomodulatory proteins with tunable affinities

ALPINE IMMUNE SCIENCES INC9 citations85
US11230588B2Jan 25, 2022

CD80 variant immunomodulatory proteins and uses thereof

ALPINE IMMUNE SCIENCES INC6 citations85
US11753458B2Sep 12, 2023

CTLA-4 variant immunomodulatory proteins and uses thereof

ALPINE IMMUNE SCIENCES INC6 citations84
US10882914B2Jan 5, 2021

ICOS ligand variant immunomodulatory proteins and uses thereof

ALPINE IMMUNE SCIENCES INC8 citations83
US11498967B2Nov 15, 2022

CD80 variant immunomodulatory proteins and uses thereof

ALPINE IMMUNE SCIENCES INC2 citations72
US11479609B2Oct 25, 2022

CD80 variant immunomodulatory proteins and uses thereof

ALPINE IMMUNE SCIENCES INC2 citations72
US11359022B2Jun 14, 2022

CD80 variant immunomodulatory proteins and uses thereof

ALPINE IMMUNE SCIENCES INC2 citations72
US12065476B2Aug 20, 2024

PD-1 variant immunomodulatory proteins and uses thereof

ALPINE IMMUNE SCIENCES INC2 citations71
US12486312B2Dec 2, 2025

Immunomodulatory proteins with tunable affinities

ALPINE IMMUNE SCIENCES INC0 citations62
US12297253B2May 13, 2025

Multi-domain immunomodulatory proteins and methods of use thereof

ALPINE IMMUNE SCIENCES INC0 citations62
US12110339B2Oct 8, 2024

ICOS ligand variant immunomodulatory proteins and uses thereof

ALPINE IMMUNE SCIENCES INC0 citations62
US12358969B2Jul 15, 2025

CTLA-4 variant immunomodulatory proteins and uses thereof

ALPINE IMMUNE SCIENCES INC0 citations61
US11613566B2Mar 28, 2023

Variant ICOS ligand immunomodulatory proteins and related compositions and methods

ALPINE IMMUNE SCIENCES INC1 citations61
US11471488B2Oct 18, 2022

CD155 variant immunomodulatory proteins and uses thereof

ALPINE IMMUNE SCIENCES INC1 citations61
US11834490B2Dec 5, 2023

CD112 variant immunomodulatory proteins and uses thereof

ALPINE IMMUNE SCIENCES INC1 citations60
US11732022B2Aug 22, 2023

PD-L2 variant immunomodulatory proteins and uses thereof

ALPINE IMMUNE SCIENCES INC1 citations60
US12552853B2Feb 17, 2026

CD86 variant immunomodulatory proteins and uses thereof

ALPINE IMMUNE SCIENCES INC0 citations55

A ALPHA BIO INC

1 patent

A ALPHA BIO

1 patent